Back

Myocardial interstitial fibrosis as a prognostic factor for right ventricular failure post left ventricular assist device implantation

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: LVADs - long term outcomes and maximisation of care Ventricular Assist Devices HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Michael Bonios

Onassis Cardiac Surgery Center, Athens (Greece)

6 More presentations in this session

Presentation thumbnail
The effect of HeartMate 3 on quality of life in advanced heart failure: results from a cohort study using EQ-5D-5L
Doctor I. Santos (Ponta Delgada, PT)
Abstract Slides Video
Presentation thumbnail
Impact of digoxin utilization on gastrointestinal bleeding in patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis
Doctor B. Pitta Gros (Lausanne, CH)
Abstract Slides Video
Presentation thumbnail
Breaking barriers in heart failure: baseline characteristics and insights from ultra-long LVAD survivors on the STELLAR Register
Mr C. Velasquez-Silva (Bad Oeynhausen, DE)
Abstract Slides Video
Presentation thumbnail
Ultra-long LVAD recipients: a new heart failure phenotype?
Doctor W. Nielsen (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
The impact of pre-implantation hemodynamic parameters on mortality post-Heartmate 3 implantation: an in-depth analysis
Mr D. Verikas (Kaunas, LT)
Abstract Slides Video

Access the full session

Session thumbnail
LVADs - long term outcomes and maximisation of care

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Inflammation and fibrosis analysis on a systemic and tissue level in adult patients with a systemic right ventricle
thumbnail
Congress Presentation
Effect of intra-aortic balloon pump support in right ventricular function in heart failure candidates for left ventricular assist device implantation and the prognostic role of interstitial fibrosis
thumbnail
Congress Presentation
Progression of myocardial fibrosis is the major determinant of heart failure hospitalization in patients undergoing transcatheter aortic valve implantation.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources